Introduction: Prostate cancer is one of the leading causes of morbidity and mortality among men in Brazil, especially in the elderly population over 65 years of age. In the Northern Region, according to the National Cancer Institute (INCA), a total of 2,760 new cases were estimated for 2023, with a crude rate of 38.88 cases per 100,000 inhabitants, while Brazil's national crude rate is 55.49 per 100,000. Thus, the analysis of hospital data can reveal important patterns of illness and mortality, highlighting the growing demand for oncological care and the financial impact associated with hospitalizations. Objectives: This study aimed to analyze the number of hospitalizations, deaths, and hospital expenses related to prostate cancer in the states of the Northern Region of Brazil, from 2015 to 2024. Methods: This is an ecological and descriptive study based on the Hospital Information System (SIH), provided by DATASUS. The data were organized and tabulated using Microsoft Excel, where a quantitative analysis was performed on hospitalizations, deaths, hospital costs, and distributions by age group and race/ethnicity of patients. Results: From 2015 to 2024, a total of 12,626 hospital admissions and 1,683 deaths due to prostate cancer were recorded in the Northern Region. The year 2024 registered the highest number of hospitalizations (1,590) and deaths (224). However, the year with the highest proportion of hospital expenses was 2023, accounting for 13.92% of the total in the analyzed period. The state of Pará stood out with the highest number of hospitalizations (4,434) and also the highest expenses, representing 40.89% of hospital costs related to prostate cancer. In contrast, Amapá had the lowest number of hospitalizations (490), while Acre recorded the lowest number of deaths (76). Age group analysis revealed a progressive increase in hospitalizations and deaths with advancing age, with individuals over 80 years being the most affected, accounting for 15.01% of hospitalizations and 26.44% of deaths. Regarding race/ethnicity, the mixed-race population (pardo) was the most affected, accounting for 75.13% of hospitalizations. Although the Northern Region presents the lowest absolute numbers in the country, the data reveal concerning patterns of hospitalizations and deaths. Conclusion: The results highlight the significant burden that prostate cancer places on the hospital system of the Northern Region, especially in states like Pará. The increase in hospitalizations and deaths with age underscores the need for preventive strategies and early diagnosis aimed at the elderly population. The predominance of hospitalizations among mixed-race individuals points to inequalities that must be addressed through early, equitable, and effective public health policies. Understanding this data can support actions to reduce mortality and hospital costs associated with this neoplasm.
It is with great enthusiasm that we present the Annals of the Oncology International Symposium 2025, an event that continues to solidify its significance in the oncology landscape of northern Brazil. Held in Belém, Pará, Oncology 2025 centered around the theme "The cancer control challenge: better knowing it to best facing it," dedicating itself to exploring the latest frontiers in cancer treatment and prevention.
This year, the symposium provided a deep dive into the essential role of knowledge in the fight against cancer, presenting new perspectives and scientific advancements across various areas of oncology. Renowned global experts gathered to share their most recent research and innovative approaches, offering participants a comprehensive view of the challenges faced by healthcare professionals and patients worldwide.
Presentations and discussions during the event focused on critical topics such as the use of new technologies, advancements in personalized therapies, and more effective prevention strategies. Additionally, particular attention was given to the unique challenges faced by the Amazon region, with efforts aimed at developing region-specific solutions to meet local needs.
Beyond being a high-caliber academic event, Oncology 2025 stood out as a moment for integration and professional networking, with the warm hospitality of the city of Belém offering participants a unique experience. This event became a platform for exchanging ideas, where science, culture, and humanity came together in pursuit of a common goal: to improve cancer control both in Brazil and globally.
This collection of abstracts and articles presented during the event reflects the ongoing dedication to research and the development of innovative solutions, highlighting the importance of collaboration and shared knowledge in the fight against cancer.
General Submission Guidelines:
The presenting author, who does not have to be the first author, must be registered for Oncology 2025.
Each abstract may have up to 10 authors, including the main author and co-authors.
Only original, unpublished work will be accepted.
Submissions must be related to oncology. However, project descriptions, work proposals, experience reports, and literature reviews will not be considered.
Clinical case reports are allowed, provided the abstract addresses scientific questions, details clinical observations, and includes primary scientific data.
The abstract must be written in English, but presentations may be given in Portuguese.
Abstracts must be between 300 and 500 words.
Comissão Organizadora
Comissão Científica
See Annals of Oncology 2023 at:
https://www.even3.com.br/anais/oncology-2023-international-symposium/
Complete tool for submission, evaluation and publication of proceedings for scientific events.
